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Memory: A Systems Biology Perspective on Random
X-Chromosome Inactivation
Verena Mutzel and Edda G. Schulz*
X-chromosome inactivation ensures dosage compensation between the sexes
in mammals by randomly choosing one out of the two X chromosomes in
females for inactivation. This process imposes a plethora of questions: How
do cells count their X chromosome number and ensure that exactly one stays
active? How do they randomly choose one of two identical X chromosomes
for inactivation? And how do they stably maintain this state of monoallelic
expression? Here, different regulatory concepts and their plausibility are
evaluated in the context of theoretical studies that have investigated threshold
behavior, ultrasensitivity, and bistability through mathematical modeling. It is
discussed how a twofold difference between a single and a double dose of
X-linked genes might be converted to an all-or-nothing response and how
mutually exclusive expression can be initiated and maintained. Finally,
candidate factors that might mediate the proposed regulatory principles are
reviewed.
1. Introduction
The mammalian X chromosome carries about 1000 genes that
mostly fulfill similar functions in males and females. They are
however present as two copies in females and only as a single
copy in males, resulting in dosage imbalance between the sexes.
Mammals have evolved the process of X-chromosome inactiva-
tion (XCI), where one X chromosome is nearly completely si-
lenced in females to ensure dosage compensation of X-linked
genes.While XCI is imprinted inmarsupials such that always the
paternal X is inactivated, in placental mammals, each female cell
randomly selects one X chromosome that will be silenced dur-
ing early embryonic development.[1–3] Random XCI makes the
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female sex more robust to pathogenic X-
linked mutations and might contribute to
phenotypic diversity.[4]
Initiation of XCI is controlled by the
X-inactivation center (Xic), a genomic re-
gion that encodes the long non-coding RNA
(lncRNA) Xist, the master regulator of X in-
activation, and a series of other genes that
regulate Xist (Figure 1) (reviewed in ref. [5]).
Xist is expressed exclusively from the inac-
tive X chromosome (Xi) and coats the entire
chromosome in cis. Acting as a scaffold for
a multitude of RNA binding proteins and
potentially forming a phase-separated com-
partment, Xist recruits members of differ-
ent gene-silencing pathways, orchestrating
chromosome-wide gene repression.[6–10] A
small subset of genes however can resist si-
lencing and thus escape X inactivation.[11,12]
All placental mammals studied so far express Xist from one
out of two X chromosomes in female somatic cells, indicating
that the outcome of XCI is similar across species. Increasing evi-
dence suggest that at least a subset of cells will initially upregulate
Xist from both chromosomes (biallelic), as observed inmice, rab-
bits, and humans.[15–18] Such biallelic upregulation appears to be
less frequent in mice than in rabbits, but is quickly resolved to
monoallelic expression in both species.[15–18] In human embryos
by contrast, Xist is upregulated from both chromosomes in all
cells, but initially fails to induce complete silencing and thus per-
sists for several days.[15,19] At a later developmental time point
which has not yet been observed experimentally, Xist must then
be downregulated from one allele. Mice have also evolved an im-
printed form of XCI, which does not occur in most other mam-
mals, preceding randomXCI in the preimplantation embryo and
resulting in inactivation of the paternal X chromosome in all
cells.[20,21] In the inner cell mass of the blastocyst, which will give
rise to the embryo, the imprint is erased and Xist is repressed by
pluripotency factors, such as Nanog and Rex1/Zfp42.[22–25] Sub-
sequent downregulation of pluripotency factors derepresses Xist,
thereby initiating random X inactivation, where either the mater-
nal or paternal X are inactivated with equal probability. Once ran-
domXCI has been established, the inactive state is maintained in
all somatic cells throughout all further cell divisions.
Whether XCI is initiated depends only on the number of X
chromosomes present in the cell, but not on the Y chromosome.
XO females with Turner syndrome do not undergo XCI, while
XXY males with Klinefelter syndrome inactivate one of their X
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Figure 1. The mouse X-inactivation center (Xic). Schematic representation of the region chrX:103184059-103981285 (mm10) in the mouse genome.
Genes colored in red and blue indicate Xist activators and repressors, respectively, a striped pattern marks lncRNA genes. Gene annotation and genomic
coordinates from UCSC RefSeq mm10, except for Xite (depicted from the minor to the major Tsix promoter) and Linx.
chromosomes.[26] Females with X trisomy (XXX) will even in-
activate two X chromosomes, implying that exactly one X chro-
mosome remains active in diploid cells no matter how many X’s
are present.[27] Studies in polyploid embryos and stem cells have
shown that also autosomal ploidy modulates XCI in a way that
one X remains active per diploid autosome set.[28–31]
2. X-Chromosome Inactivation Concepts
One of the most fascinating aspects of XCI is that two function-
ally equivalent X chromosomes within the same nucleus assume
completely different fates. To this end, a cell must first assess
how many X chromosomes it possesses and only initiate XCI if
it has more than one (per diploid set of chromosomes). Each cell
must then choose one (or more) X to inactivate (Xi) and one X
to stay active (Xa). Once this decision has been made, it must
be stably maintained (Figure 2a). The terms counting and choice
have been introduced to describe these processes. Counting is the
process that determines how many X chromosomes need to be
inactivated while choice refers to the decision of which X to inac-
tivate. Mary Lyon proposed the process of XCI in 1961.[1] In the
almost 60 years since she postulated her hypothesis numerous
concepts have been developed to explain counting and choice.
2.1. How Can Cells Count Their X Chromosomes to Ensure
Female Specificity of XCI?
Which regulatory principles ensure that XCI is initiated only in
cells with two ormore X chromosomes, but never inmales with a
single X? In principle, the default fate of the X chromosome could
either be to get inactivated (default:Xi, Figures 2b–e and 3a,b)
or to stay active (default:Xa, Figures 2f,g and 3c,d). In the first
case, one X in each cell, whether male or female, would have to
be protected from XCI, while in the latter, cells would have to
sense the presence of two X chromosomes and induce XCI only
in females.[32]
Several mechanisms have been proposed to protect the ac-
tive X in the default:Xi scenario. In early models, often a pro-
tective molecule or complex that is present only once in each cell
was invoked. This could be a single nuclear attachment site that
protects the attached chromosome from XCI (Figure 2b)[33] or
a “blocking factor” that is present as a single molecule and can
thus bind only one X chromosome (Figures 2c and 3a).[32,34–36]
We know today, however, that the precision of gene expression
is limited by the laws of thermodynamics that govern all bio-
chemical reactions.[37–39] Thismakes it impossible to reliably pro-
duce a single molecule of an RNA or protein in each cell. To ad-
dress this limitation, the protecting factor has been suggested to
self-assemble into one large cluster of molecules (self-assembly
model, Figure 2d).[40,41] Biophysical simulations have shown that
this would be possible within biologically relevant timescales,
if the X chromosomes are in close spatial proximity (Xic pair-
ing, see below). Spatial colocalization would strongly reduce the
search time in 3D space for individual molecules to find a clus-
ter. One of the earliest XCI models suggested the insertion of
an episomal DNA element in one X leading to activation of that
chromosome (Figure 2e). Among the activated genes would be
one encoding a factor that would rapidly degrade all remaining
episomes in a negative feedback loop.[42] Despite large-scale se-
quencing efforts, however, no Xa-specific DNA insertions have
been identified. Therefore, we can probably reject this model
today.
Also for the alternative defaut:Xa scenario different mecha-
nisms have been suggested (Figure 2f,g). Homologous pairing
of two X chromosomes had, for example, been thought to allow
sensing of the presence ofmore than one X (Figure 2f).[43–45] This
hypothesis has however been falsified recently, because reduc-
tion of pairing through tethering one or both Xic’s to the nuclear
lamina does not affect XCI.[46] Moreover, work in heterokaryons
showed that diffusible factors are sufficient to induce XCI in an
XY nucleus.[47] Already in 1971, Mary Lyon proposed a diffusible
X-encoded factor to ensure female-specific XCI.[32] We will call
this factor X-linked XCI activator (xXA). Because it is encoded
on the X chromosome, this activator gene would be present in
two copies in each female cell and its gene product (RNA or pro-
tein) would thus be present at twice the levels in females com-
pared to males (Figures 2g and 3c). A central prediction of the
xXA model is that additional X chromosomes will increase the
rate with which XCI is initiated, a concept that has been veri-
fied experimentally.[31] An essential ingredient of any XCI model
that relies on an xXA is that xXA initiates XCI in a switch-like
manner once it exceeds a certain threshold that lies between the
xXA level in male and in female cells (Figure 4a).[31] Accordingly,
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all supernumerary X chromosomes in X-aneuploidies (e.g., XXX,
XXY) are silenced until only a single active X (single xXA dose)
remains.
2.2. Molecular Implementation of the XCI Initiation Threshold
Required for X Dosage Sensing
The XCI initiation threshold is required to convert a twofold
difference in xXA levels between males and females into a bi-
nary decision, where XCI is initiated in females only. Such
a threshold response requires ultrasensitivity, where a small
change in input signal (xXA dose) results in a large effect on
the response (Figure 4a). Ultrasensitivity can, for example, arise
from molecular titration, cooperative binding or positive feed-
back regulation,[48,49] and either arise globally or locally at the
allele-level (Figure 4b,c).
A global threshold response could be mediated by sequestra-
tion of xXA through an (autosomal) XCI repressor or through
autosomal binding sites on the DNA.[50,51] Only if xXA is
Figure 2. XCI models. a) Only female cells with two X chromosomes (right), but not males with a single X (left) initiate XCI (female specificity) through
Xist upregulation (green) from one out of two X chromosomes (gray) in a monoallelic fashion (mutually exclusive choice) and stably maintain this deci-
sion throughout cell division (maintenance). b,c,d,e) Models assuming inactivation as the default fate for the X chromosome (Default:Xi). In Default:Xi
scenarios female specificity is ensured through a single entity (blue) that will protect exactly one X chromosome from inactivation. This entity can be b)
a nuclear attachment site, c) a single molecule blocking factor, d) a self-assembling protective cluster, or e) an episome, which is inserted into one of the
two X chromosomes, followed by rapid degradation of all remaining episomes. f,g) Models assuming activity as the default fate for each X chromosome
(Default:Xa). In default:Xa scenarios, presence of two X chromosomes is necessary to initiate XCI and is sensed through f) Xic pairing, or g) a diffusible
trans-acting X-encoded XCI activator (xXA) that is present in a double dose in female cells and activates XCI in a dose-dependent manner.
Female specificity Mutually exclusive choice and maintenancea
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Figure 3. Networkmotifs implicated in the onset of XCI. a) In the Default:Xi scenarios a single entity autosomal XCI repressor (aXR, blue square) ensures
female specificity by inhibiting XCI on exactly one X chromosome (gray) per nucleus. b) Stable protection of one X from inactivation could be ensured
by mutual repression of the two X chromosomes (global toggle switch), for example, through a single self-assembling cluster of protective factor (blue)
that associates with one X chromosome, resulting in depletion from the other X by acting as a sink for the protective factor (global toggle switch).
Alternatively, an irreversible event, for example, stable DNA insertion (blue star) into one X (irreversible change) could stably protect that chromosome
from inactivation. c) In the Default:Xa models female specificity is ensured through sensing the presence of more than one active X chromosome, for
example, through an X-linked XCI activator (xXA, red circle). d) Upon XCI Xist will silence the trans-acting xXA thereby inhibiting Xist upregulation from
the other Xist allele but also itself (mutual- & self-inhibition), because xXA activates both Xist alleles. To nevertheless maintain Xist expression at the Xi,
an additional positive feedback is required that acts in cis to locally stabilize Xist expression upon xXA silencing (local toggle switch). The self-reinforcing
positive feedback can be mediated by mutual repression between Xist (green) and a cis-acting Xist repressor (xXR, blue), for example, Tsix, which stably
maintains two alternative states, where xXR dominates on the Xa (left) and Xist dominates on the Xi (right).
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Figure 4. XCI threshold. a) An ultrasensitive stimulus-response curve is required in all xXA models. A twofold change in xXA concentration (red dots)
must result in a sharp switch-like XCI response to convert a quantitative signal (1x or 2x xXA dose) into a binary all-or-nothing response (No XCI or
XCI). b,c) Possible molecular implementations of the ultrasensitive threshold response. b) A global threshold at the cell level can be implemented, for
example, by sequestration of xXA (red) through an autosomal XCI repressor (aXR, blue), where free xXA (xXAfree) becomes only available to bind and
activate Xist, when the xXA concentration (xXAtotal) exceeds that of aXR. c) A local threshold at the allele level can be implemented by positive cooperative
binding (top) of multiple xXA molecules to a binding site cluster (red bars) at the Xist locus, such that initial xXA binding increases the binding affinity
of the remaining unbound xXA sites. Alternatively, a local threshold can be generated by a cis-acting positive feedback (bottom), where Xist reinforces
its own expression in cis. The positive feedback also has the potential to produce bistability, resulting in two alternative stable states (gray circles) in
the presence of a single xXA concentration, corresponding to the Xa and Xi. Dashed lines indicate the transitions, where the low or high steady states
become unstable. Gray arrows indicate hysteresis, where different steady states are reached depending on the previous state of the locus. d) Autosomal
ploidy can be integrated through an aXR that counteracts xXA (see b) such that xXA is completely sequestered in both male diploid (2n1X) and tetraploid
(4n2X) cells (left), or through dilution of xXA due to increased nuclear volume, resulting in the same xXA concentration in 2n1X and 4n2X cells (right).
produced from two X chromosomes some of it would remain
unsequestered and could bind to the Xist locus to activate tran-
scription (Figure 4b). Global threshold behavior could in prin-
ciple also arise if xXA would control production of another, po-
tentially autosomally encoded downstream activator in an ultra-
sensitive manner.[32,50] If the threshold was established locally at
the level of Xist regulation, it could arise from cooperative bind-
ing of multiple xXA factors to the Xist locus, or from a cis-acting
positive feedback loop, a concept that we have recently proposed
(Figure 4c).[16]
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2.3. How Does Autosomal Ploidy Modulate XCI?
Can these concepts explain how autosomal ploidy ensures that
female diploid cells (XX, AA) initiate XCI while tetraploid male
cells (XXYY, AAAA) do not, although they both have two X chro-
mosomes? The default:Ximodels are in general limited to diploid
cells, because generation of exactly two stable protective clusters
is even more difficult to envision than generation of a single one.
The xXA models by contrast can explain XCI in tetraploid cells
by invoking an autosomal XCI repressing factor that would scale
with the number of autosomes and counteract xXA.[30,31,36,51,52]
Such a repressor could, for example, sequester xXA and would
thereby essentially shift the XCI initiation threshold (Figure 4d,
left) or modulate a local threshold by competing with xXA for
binding to the Xic (Figure 4c).[31,36,51] Recently, we have proposed
an explanation for how autosomal ploidy might affect XCI that is
independent of such an autosomal repressor. Twofold dilution of
xXA factors due to an about twofold increase in nuclear volume
in tetraploid cells would result in similar xXA concentrations in
XY and XXYY cells,[16,53] allowing both to remain below the XCI
threshold (Figure 4d, right).
2.4. How Can Mutually Exclusive Initiation of XCI from Exactly
One X Chromosome Per Cell Be Ensured?
At the onset of XCI, two functionally equivalent chromosomes
must assume opposing transcriptional states. The problem
resembles a much better studied situation, where two simi-
lar progenitor cells assume alternative cell fates. This is often
ensured through mutual inhibition of two lineage-determining
transcription factors.[54,55] Such a network motif can generate a
toggle switch, which can assume two alternative states, where one
factor is active and represses the other one and vice versa.[56] In
addition, expression of each factor is often stabilized by positive
feedback regulation, giving rise to the so-called “extended toggle
switch”.[55] In this analogy, the two X chromosomes or factors
encoded by them would resemble the two lineage-determining
transcription factors, with the important difference that the
two chromosomes are identical, making pure mutual inhibition
more challenging. The self-assembly model would in principle
generate such purely reciprocal inhibition of XCI at the two X
chromosomes, because one assembled cluster would act as a sink
and thus prevent binding of the factor to the other chromosome
(Figures 2d and 3b, left). As discussed above, however, the self-
assembly model cannot explain observations in tetraploid cells.
In principle, also the Xi as a whole could act as a sink by seques-
tering heterochromatin components, as suggested for the Y chro-
mosome in drosophila, and thereby prevent silencing of the sec-
ond X chromosome.[57,58] The inhibition would however not be
X-specific and would reduce heterochromatin formation also on
autosomes.
For the models invoking an X-linked activator, Mary Lyon had
already proposed in 1971 that silencing of xXA upon XCI could
prevent inactivation of the other X chromosome by reducing the
xXA dose to the level found inmale cells, thus constituting a neg-
ative feedback loop (Figures 2g and 3d).[32] The feedback would
however not be purely reciprocal: Since xXA acts on both chromo-
somes, silencingwould also inhibit XCI on the inactive X, thus re-
quiring additional self-reinforcing mechanisms to maintain the
inactive state in the presence of reduced xXA levels, as discussed
in the next section (Figure 3d). Interestingly, a similar negative
feedback has already been proposed as early as 1963 in the epi-
some model,[42] where episome integration triggers degradation
of all remaining unincorporated episomes (Figure 2e).
An important requirement of any global negative feedback
model is a separation of timescales. If the initial event of XCI,
such as Xist upregulation, is slow and stochastic, it will gen-
erally occur at one chromosome at a time and thereby allow
symmetry breaking. The subsequent negative feedback, that is,
xXA silencing, must, by contrast, be fast to prevent reoccurrence
of the initial event on the second X chromosome.[51] The ini-
tial probabilistic event underlying symmetry breaking could also
occur upstream of Xist upregulation, for instance by switching
to a permissive chromatin or conformational state (pre-emptive
choice).[59,60] It is however difficult to explain how such a purely
cis-acting mechanism could result in mutual exclusivity.
Preventing Xist upregulation from the second X, seems not
to be the only function of the proposed negative feedback loop,
mediated by silencing of xXA. If cells erroneously initiated XCI
on the single X in males or biallelically on both X chromosomes
in females, complete xXA silencing could reverse initiation of
XCI. In support of this idea, we have recently shown that bial-
lelic XCI initiation is indeed reversible.[16] The xXA-mediated
feedback loop might therefore govern the reversion of biallelic
Xist expression, which is observed to varying extents in different
species, to the final monoallelic expression pattern.[15–18] More-
over, it might reverse Xist upregulation in male cells, as recently
observed in mouse embryos.[17]
2.5. Maintenance of Monoallelic Expression through Bistability
and Epigenetic Memory
To ensure stable monoallelic XCI, the inactive state must,
once established, be maintained throughout cell divisions. The
biochemical reactions that govern transcriptional regulation are
in general reversible except for changes to the DNA sequence.
This irreversibility of DNA insertions was suggested in the epi-
some model to allow stable maintenance (Figures 2e and 3b,
right).[42] However, our recent finding that cells are able to re-
vert biallelic to monoallelic Xist expression suggests that choice
is initially reversible arguing against the occurrence of a single
irreversible event.[16] It thus seems more likely that dedicated
self-reinforcing mechanisms ensure stable maintenance of the
active and inactive states (Figure 3d).[16,31,32] By systematic test-
ing of different regulator types through mathematical model-
ing we have recently shown that such a self-reinforcing, posi-
tive feedback could be mediated by an X-linked regulator that
functions as an Xist repressor in cis.[16] Since such a regulator
would be silenced by Xist during XCI, Xist and the repressor
would mutually repress each other, thus forming an additional
local toggle switch in cis (Figure 3d). Such a switch could gen-
erate local bistability, which would allow stable maintenance of
two alternative expression states at the two X chromosomes in
the presence of a single activator dose (Figure 4c, bottom). Al-
ternatively, a self-reinforcing feedback could also function up-
stream of Xist upregulation, for example, mediated by other
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cis-acting mechanisms such as chromatin modifications and
could lead to pre-emptive choice (see above).[61] As discussed
above, a positive feedback loop can also give rise to ultrasensitivity
to generate the threshold behavior required for female specificity
and would thus ensure both, stable maintenance of alternative
states and the threshold required for female-specific XCI (Fig-
ure 4c, bottom).
2.6. Emerging Concepts: Ultrasensitivity and Feedback Loops
In summary, the default fate of the X chromosome appears to
be the active state and initiation of XCI is triggered by one or
several X-linked XCI activators. The required threshold response
could be implemented in a global manner, such that the activator
is only active in female cells, for example, through sequestration
by an autosomal repressor. Alternatively, the threshold could be
generated through cis-regulatory events at the Xist locus for in-
stance through cooperative binding of xXA to the Xic, or through
local feedback regulation. Autosomal ploidy could modulate the
threshold either through autosomal XCI repressors that counter-
act the activator or through dilution of the activator due to in-
creased nuclear volume. Rapid silencing of the X-linked activa-
tor, once XCI has been initiated, could ensure mutually exclu-
sive choice, if the inactive state is memorized in cis, for example,
through a local positive feedback loop.
Similar mechanisms have been invoked in ensuring mutual
exclusive expression in other biological contexts such as the dif-
ferentiation of olfactory neurons, where each cell must make a
stochastic but stable choice for exactly one out of about 1000
different olfactory receptors. Also here, the mutually exclusive
choice of a single receptor is mediated by a global negative feed-
back, triggered by activation of a receptor gene, and the decision
is locked in by a local positive feedback mediated by nucleosome
modifications.[62–66]
3. Candidate Regulators and Mechanisms
A series of abstract concepts of how random XCI can be ensured
have been proposed and partially rejected again over the years.
To test the emerging concepts, we now have to identify the pre-
dicted regulators. If not stated otherwise, all observations dis-
cussed in the next sections were made in mouse embryonic stem
cells (mESC), the main cell culture model of XCI.
3.1. xXA Factors: Rnf12 and Accomplices
To ensure female-specific XCI an xXA factormust be expressed at
twofold higher levels in females compared to males, and it must
activate XCI in a switch-like manner that allows for an all-or-
nothing decision within this twofold range. To mediate the pre-
dicted negative feedback, xXA should be rapidly silenced during
XCI. Moreover, its overexpression inmale cells should induce ec-
topic XCI, while a heterozygous xXA deletion should abolish XCI
in females and thus result in female-specific lethality.
The best studied xXA factor is the Rnf12/Rlim gene, which
encodes an E3 ubiquitin ligase and is located close to Xist (Fig-
ure 1).[67] Rnf12 activates Xist by targeting the autosomally en-
coded XCI repressor and pluripotency factor, Rex1 for degrada-
tion (Figure 5a).[25,68] Rnf12 clearly functions as a dose-dependent
Xist activator, as its overexpression in male cells results in ec-
topic XCI, and is rapidly silenced by Xist.[67] Its heterozygous
deletion in females, however, does not abolish, but only delay
XCI.[67] Complete absence of Rnf12 by contrast prevents ran-
dom XCI in differentiating mESCs and imprinted XCI in early
mouse embryos, while random XCI in vivo has been reported
to be unaffected.[69–71] The mESC phenotype, however, seems
to depend on the precise culture conditions,[72] maybe because
rapid downregulation of Rex1 under certain conditions might
make XCI Rnf12-independent. Interestingly, experiments with
heterozygous Rnf12 mutants where the single intact copy of
Rnf12 is silenced during XCI have shown that XCI cannot be
maintained without an active Rnf12 allele.[47] This supports the
above-discussed idea that biallelic XCI in femalesmight be unsta-
ble because it results in complete xXA silencing.[47] The fact that
loss- and gain-of-function perturbations of Rnf12 result in asym-
metric phenotypes, suggests that additional xXA factors exist. If
multiple xXAs act together in a redundant or additive manner,
overexpressing one xXA factor should result in ectopic XCI in
males but its heterozygous deletion would not necessarily abol-
ish XCI in females as other xXAs could compensate for the loss.
Such a cooperation of multiple xXA factors might also facilitate
robust X-dosage sensing, as individual genes often exhibit higher
than twofold cell-to-cell expression variability.[73]
An X-linked activator that might potentially cooperate with
Rnf12, is the lncRNA Jpx, which is located about 10 kb upstream
of Xist and has been suggested to activate XCI by evicting Ctcf
from the Xist gene (Figures 1 and 5a).[74,75] While its function as
an XCI activator is well established, its mechanism of action and
whether it can act in trans remain controversial.[47,76] Moreover,
Jpx escapes XCI both in mice and in humans and can thus not
be invoked for the predicted negative feedback regulation.[75,76]
Yet another Xist-activating lncRNA, named Ftx, is located about
100 kb upstream of Xist (Figures 1 and 5a).[77,78] Ftx activates Xist
in cis by the act of transcription, independent of its lncRNA and
the microRNA cluster it contains, and can therefore not be one
of the trans-acting xXA factors that have been predicted to under-
lie female specificity.[78] In conclusion, several positive X-encoded
regulators of Xist have been identified, but additional factors nec-
essary to mediate female-specific XCI onset remain to be found.
3.2. XCI Initiation Threshold: Yy1—Rex1 Competition or
Antisense Transcription?
Ultrasensitivity, which is required for the predicted XCI initia-
tion threshold, can be generated, for example, through molec-
ular titration, cooperative binding or positive feedback regula-
tion as explained above.[48] Jpx has been proposed to establish
an XCI threshold by titrating the autosomal XCI repressor Ctcf
away from the Xist locus, which, when overexpressed prevents
Xist upregulation.[74] It remains unclear, however, how a rather
lowly expressed RNA could titrate a highly abundant protein[79]
and how the effect could be specific to Xist regulation although
Ctcf is found at a large number of genomic locations.
Instead, ultrasensitivity might rather arise from cis-regulatory
events at the Xic. Cooperative binding of transcription factors
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could in principle occur, if multiple binding sites are clustered
together. Interestingly, the autosomally encoded ubiquitous tran-
scription factor Yy1, which is essential for initiation and main-
tenance of Xist expression (Figure 5a), binds to a highly con-
served cluster of binding sites in the 5′ region of Xist and also
to Tsix.[80–83] While Yy1 is bound to all X chromosomes before
XCI, its binding becomes restricted to the Xist-expressing al-
leles at the onset of XCI (Figure 5b, red square).[81,82] Two re-
lated transcription factors, Rex1 and Yy2, were derived from Yy1
through retrotransposition in placental mammals and have sim-
ilar binding motifs.[84] The Xist repressor Rex1, which is targeted
for degradation by Rnf12 (see above), indeed functions at least
in part, through competing for binding with Yy1.[82] Accordingly,
Yy1 knock-down dramatically impairs Xist upregulation at the
onset of differentiation in female mESCs,[82] while Rex1 deple-
tion in male cells results in ectopic Xist upregulation.[25,67] Inter-
estingly, Yy2, which is poorly characterized, is located on the X
chromosome and could thus also contribute to female specificity
if functioning as an Xist activator. Taken together, the clustered
Rex1/Yy1 binding sites could generate the threshold required to
distinguish between a single and a double dose of Rnf12, if Yy1
bound in a cooperative manner (Figure 5b).
An alternative mechanism to generate ultrasensitivity would
be positive feedback regulation, for example, mediated bymutual
inhibition of Xist and an cis-acting Xist repressor (see above).[16]
The best studied cis repressor is Tsix, a lncRNA locus antisense to
Xist, which completely overlaps with the Xist gene, including its
promoter (Figures 1 and 5a,b).[36,85] Tsix transcription establishes
a repressed chromatin state at the Xist promoter and might addi-
tionally repress Xist by transcriptional interference.[16,86–89] Tsix
clearly functions in cis only, as heterozygous Tsix deletions skew
the choice of the inactive X toward the mutated allele.[36,59,90,91]
Through a mathematical model of transcription at the Xist/Tsix
locus, we have shown that antisense transcription can indeed
maintain alternative Xist expression states on Xa and Xi.[16]
Repression of Xist by Tsix also delays the kinetics of Xist up-
regulation and can therefore ensure the required timescale sepa-
ration (slow XCI initiation, fast negative feedback). Accordingly,
Tsixmutations accelerate Xist upregulation[31] such that homozy-
gous Tsix deletions result in a weakened timescale separation be-
tween Xist upregulation and xXA silencing and a higher fraction
of biallelic cells.[52]
The functional conservation of Tsix in other species is unclear.
In human embryonic carcinoma cells, the overlap between XIST
and TSIX is reduced, such that antisense transcription does not
reach the XIST promoter.[92] Our simulations showed that, even
with this reduced overlap, the required sharp threshold response
can be generated within a twofold range of xXA, if we assume
transcriptional interference, which is supported by experimental
evidence.[16] However, TSIX transcription has not been observed
in human embryos or embryonic stem cells.
Alternative cis-acting Xist repressors could be Xite and
Linx, two other lncRNA loci that have been implicated in
Xist regulation (Figures 1 and 5a).[93,14] Xite is a Tsix en-
hancer whose deletion results in downregulation of Tsix in
cis and mildly skewed XCI.[93,94] Thus, rather than being
an independent Xist repressor, Xite acts upstream of Tsix.
Linx, on the other hand, represses Xist in cis, but inde-
pendently of its transcription, thus rather functioning as a
cis-regulatory DNA element,[95] which makes it potentially insen-
sitive to Xist-mediated silencing and therefore incapable of me-
diating the double-negative feedback.
The human-specific lncRNAXACT also antagonizes XIST and
its expression pattern in primed hESCs fits with a role as X-linked
repressor: XACT coats the Xa while XIST coats the Xi.[96] In ad-
dition, XACT transgenes in mESCs can prevent Xist accumula-
tion in cis.[97] However, XACT is initially expressed together with
XIST from all X chromosomes in human embryos.[96,97] This co-
expression would be compatible with an XACT-mediated positive
feedback loop, if mutual repression (XACT silencing and XIST
repression by XACT) only sets in once the biallelic state gets re-
solved to the state of a female cell with one active and one inactive
X chromosome (XaXi). To test these ideas, we first need to acquire
the ability to observe onset of random XCI in human embryos or
in hESCs. Recent developments in human embryo culture and
new culture conditions for hESCs, will hopefully soon allow us
to observe this transition to the XaXi state and investigate the
functional roles of XACT and potentially TSIX.[98–101]
3.3. Integration of Autosomal Ploidy: Autosomal Regulators
Counteracting xXA
Autosomal ploidy modulates the XCI initiation threshold ei-
ther through dilution of xXA factors or through autosomal XCI
Figure 5. XCI regulators. a) Schematic wiring diagram of Xist (green) and its regulators at the onset of XCI. b) Possible molecular implementation of
female-specific monoallelic XCI onset. Shown are both X chromosomes (gray) in female (top) and the single X in male cells (bottom) before (left), during
(middle) and after (right) differentiation. Transcriptional activity of Xist, Tsix, and Rnf12 is indicated by solid dark (active) or dotted light arrows (inactive).
Free and chromatin-bound proteins are indicated as squares (Rex1, Yy1), circles (Rnf12), or triangles (Nanog). Yy1 competes with Rex1 for binding to
Xist’s first exon and can therefore only bind if Rex1 levels are low and binding sites are unmethylated. In the pluripotent state repression through Tsix
prevents Xist upregulation even on alleles with Yy1 binding. Upon differentiation, Rnf12 upregulation depletes Rex1 in female cells, generating the
opportunity for Yy1 binding and Xist upregulation. Xist repression by other pluripotency factors such as Nanog ensures slow monoallelic on-switch of
Xist. In males, binding sites remain occupied by Rex1 due to lower Rnf12 levels, and fast establishment of DNA methylation, possibly promoted by
Tsix transcription, stably prevents Yy1 binding and Xist upregulation. Upon successful dosage compensation, DNA methylation levels also rise globally
in female cells and prevent Yy1 binding to the Xa, so that in differentiated cells Tsix transcription is no longer necessary for Xist repression. c) Double
X-dosage induces XCI mediated by xXA factors, but also halts differentiation in females by maintaining pluripotency factor expression and delaying global
DNA remethylation. Faster DNA methylation might contribute to Xist repression in males, while slower downregulation of pluripotency factors might
reduce the probability for Xist upregulation in females, thereby ensuring proper XCI timing and robust monoallelic XCI. d) Hypothetical roles of sex
differences in DNA methylation and differentiation for correct XCI onset. Female XX cells (upper left) exhibit DNA hypomethylation (gray) and reduced
protein levels of the Xist repressor Rex1 (black), but slower downregulation of other Xist repressing naive pluripotency factors (blue) compared to male
XY cells (lower right). DNA hypomethylation might be required to generate an extended time window (red), where XCI can be initiated (compare left top
and bottom). Slower downregulation of pluripotency factors might be important to ensure a low XCI probability (red) required to prevent biallelic Xist
upregulation (compare top left and right).
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repressors, as discussed above. Such an autosomal repressor is
Rex1, whichmediates the effect of Rnf12 on XCI (Figure 5a,b).[25]
When comparing a diploid male cell (XY, AA) with a single X
to a corresponding tetraploid cell (XXYY, AAAA), twofold higher
Rnf12 levels in the latter could potentially be neutralized by a
twofold increase in Rex1. If we assume that ubiquitinylation of
Rex1 follows Michaelis-Menten kinetics, Rex1 levels would be
similar in both cell types, potentially explaining why they do not
initiate XCI.
Apart from Rex1, a series of additional (autosomal) pluripo-
tency factors have been found to repress XCI either directly
or via controlling Xist regulators, such as Tsix or Rnf12 (Fig-
ure 5a).[22–24,102–107] By activating Tsix or repressing Xist, they
could in principle also modulate the activation threshold of the
proposed Tsix-mediated positive feedback loop.[16] Given their dy-
namical regulation during the onset of XCI and the fact that also
autosomal activators control Xist, it might however be challeng-
ing to sense autosomal ploidy via pluripotency factor levels.
3.4. Maintenance: Which cis-Acting Positive Feedback
Mechanisms could Generate Epigentic Memory?
While Xi maintenance in somatic cells is mostly Xist indepen-
dent,monoallelic silencing initially requires the continuous pres-
ence of the Xist RNA on exactly one X chromosome.[108–111] Such
stable maintenance of two alternative Xist expression states on
two alleles in the same nucleus requires cis-acting mechanisms
that memorize the allelic expression states. We have recently
proposed that local bistability, mediated by a cis-acting positive
feedback loop could enable such a memory by constituting a
local toggle switch.[16] This feedback might be mediated by mu-
tual repression of Xist and Tsix and could generate two sta-
ble steady states, one in which Tsix dominates over Xist (Xa)
and vice versa (Xi) (Figure 3d). If Xist-mediated silencing of
an cis-acting Xist repressor such as Tsix would indeed be re-
quired to stabilize Xist expression, a perturbation of Xist’s si-
lencing capacity should prevent Xist upregulation, because it
would block one interaction in the double-negative feedback. A
failure to upregulate Xist has indeed been observed in mouse
embryos carrying a deletion of the A-repeat (∆A), which is
required for Xist’s silencing function,[112] but was interpreted
as a disruption of an Xist enhancer element.[113] Xist upreg-
ulation was restored when the ∆A allele was put under con-
trol of a strong beta-actin promoter, which can override Tsix-
mediated repression,[114] supporting a role of Xist-mediated si-
lencing in upregulation of Xist itself. Depletion of silencing
factors, such as Spen, a protein that recruits transcriptional core-
pressors and histone deacetylases to Xist,[7,8,115] would be pre-
dicted to have a similar effect. Interestingly, deletion of Spen
or its binding site in Xist reduce Xist RNA levels even in an
inducible system.[6] Also methylation of N6-methyladenosine
residues (m6A) in the Xist RNAhas been suggested to contribute,
albeit to a lesser extent, to Xist’s silencing ability.[6,116] Accord-
ingly, Xist upregulation is indeed impaired upon knockdown of
components of the m6A methylation machinery.[116] Taken to-
gether, silencing of X-linked genes seems to indeed enforce Xist
expression, supporting the notion of a silencing-dependent self-
reinforcing feedback. Given that Tsix expression is shut off as
cells differentiate, additional mechanisms must stabilize Xist ex-
pression in somatic cells.
One such candidate mechanism is DNA methylation since
knock-out of the maintenance DNA methyltransferase Dnmt1
results in derepression of Xist on the Xa in somatic cells.[117,118]
DNA methylation also plays a key role in genomic imprinting,
where two alleles of the same gene acquire alternative expres-
sion states predetermined by their parental origin.[119,120] Inter-
estingly, the regulatory region within Xist that is bound by Yy1
at the Xist-expressing chromosome, is methylated on the other
allele which prevents Yy1 binding.[81,82,121] This allelic asymme-
try suggests that DNAmethylation might be involved in a poten-
tial chromatin-based feedback loop to sustain epigenetic mem-
ory at the Xist locus (Figure 5b). However, even in the absence of
de novo methylation, most cells still exhibit the correct Xist ex-
pression pattern in vivo, suggesting that DNAmethylation is not
essential to establish alternative Xist expression states and that
additional redundant mechanisms are in place to lock in these
states.[122] Since Tsix transcription has been shown to promote
DNA methylation, the Tsix-mediated feedback and a potential
chromatin-based feedback loop might be coupled and the latter
could take over stabilization of the two states, once Tsix transcrip-
tion ceases (Figure 5b).[87]
3.5. Global X-Dosage Effects Might Help to Create a
Female-Specific Window of Opportunity
Interestingly, the presence of two active X chromosomes affects
also autosomal gene expression.[123] Double X-dosage shifts cells
toward the naive stem cell state, such that they express higher lev-
els of naive pluripotency factors, exhibit global DNA hypomethy-
lation, a hallmark of the naive state, and decreased activity of the
differentiation-promoting MAP kinase signalling pathway (Fig-
ure 5c).[124,125] Moreover, female cells differentiate more slowly
and can only leave the pluripotent state once X-dosage compensa-
tion has occurred.[124] An intriguing hypothesis that has not been
explored so far is that these sex differences could also contribute
to female specificity or robustness of XCI (Figure 5d). X inacti-
vation is initiated upon the exit from the naive pluripotent state,
which is associated with global DNA hypomethylation and thus
coincides with global remethylation of the entire genome.[120]
DNA hypomethylation and potentially slower remethylation due
to delayed differentiation in cells with two X chromosomesmight
be important to create a “window of opportunity” for Xist upregu-
lation (Figure 5d, left, compare top to bottom).[124,126] In addition,
the slower downregulation of pluripotency factors in XX females
might be required to limit the speed of Xist upregulation in order
to maintain the timescale separation between upregulation and
silencing (see above) (Figure 5d, top, compare left to right).
4. Conclusion and Prospects
In summary, a global negative feedback mediated by X-linked
XCI activators combined with a cis-acting positive feedback can
in principle ensure female-specific and monoallelic XCI. Experi-
mental evidence for the existence of the negative feedback comes
from the observation that cells are able to reverse biallelic Xist
expression.[16] The Rnf12-Rex1 axis clearly contributes to the
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feedback but additional xXA factors must exist to ensure female-
specific XCI onset. To identify these factors, their ability to in-
duce XCI when overexpressed in male cells should be assessed,
as this allows to also uncover regulators that act in combination.
To identify how the required threshold response is ensured, Xist
dose-response curves should be measured, for example, by titrat-
ing a known xXA factor, such as Rnf12. Transient overexpression
of the xXA factor might even allow us to observe the hysteresis
effect experimentally. Overexpression should induce Xist and the
positive feedback should maintain expression upon subsequent
reduction of the activator level. Once the predicted non-linear re-
sponse and the memory are directly observable, the underlying
mechanisms can be identified by experimental perturbation of
candidate regulators such as Tsix transcription, Yy1 binding or
DNA methylation.
The reason why the mechanisms mediating the two feedback
loops remain incompletely understood, might be their highly re-
dundant implementation. Given the challenge to maintain the
correct Xist expression pattern throughout all somatic cell divi-
sions and in diverse cell types, such redundant regulation might
be required to ensure robustness. To dissect the contribution of
the different mechanisms, it will be essential to perturb them
in combination and to assess the contribution of each one in
a quantitative fashion. Mathematical models provide a useful
tool for understanding the regulation of such fascinating bio-
logical processes as random XCI because they formalize concep-
tual ideas and make predictions that can be rigorously tested in
experiments.
Appendix
Autosomes All chromosomes that are not sex chromosomes. The number of autosome sets that a cell possesses determines its ploidy. Mice and
humans are diploid (2n).
Bistability The coexistence of two stable steady states for the same system’s parameters. For instance, high Xist expression on Xi and low Xist
expression on Xa in the presence of a single xXA dose.
Choice Process by which a female cell decides which of its two X chromosomes to inactivate. In random XCI the probability for the maternal and
paternal X to become inactivated is equal. However, certain Xicmutations or polymorphisms can result in preferential inactivation of
one X chromosome (skewing).
Cis A cis regulator locally affects the chromosome on which it is encoded. cis-regulatory events are necessary to allow stable opposing
expression states on the active and Xis. Long non-coding RNAs (lncRNAs) often act as cis regulators (Tsix, Linx as cis-Xist repressors,
Jpx, Ftx as cis-Xist
activators).
Cooperativity If two molecules bind in a cooperative manner, binding of the first molecule increases affinity of the second molecule.
Counting Process by which a cell determines its X-to-autosome ratio to decide how many X chromosomes must be inactivated in order to achieve a
ratio of one active X per diploid set of autosomes.
Female specificity XCI only initiates in XX females but not in XY males. An exception to this are males who have more than one X chromosome (e.g., XXY,
Klinefelter syndrome) and females with a single X chromosome (XO, Turner syndrome)
Hysteresis Memory of the system’s previous state, meaning that the system exhibits a different response depending on whether it was previously in
its “on” or “off” state. This allows Xist to stay “off” on the Xa, while being “on” on the Xi.
Maintenance Stable propagation of the decision for an active and Xi throughout all further cell divisions.
Monoallelic Expression of a gene from only one of multiple existing (and genetically identical) copies of DNA.
Toggle switch Mutual cross-inhibition between two entities resulting in bistability.[56,127] The paradigm for mutual exclusivity in biology that can explain
numerous decision-making processes, such as the lysis-lysogeny decision of phage lambda, which is mediated by mutual repression
between two transcription factors (for a review see refs. [128,129]).
Trans A trans-acting regulator affects all copies of its target gene and is usually a diffusible molecule, such as a protein or RNA. trans-regulatory
events are necessary to allow communication between the X chromosomes in a cell.
Ultrasensitivity Threshold behavior. Small changes in the stimulus close to the threshold result in a large change in the response.
Xic The X inactivation center (Figure 1) has been defined as the minimal region sufficient to trigger XCI if present in two copies.[130] Among
other important XCI regulators it contains the Xist gene, the master regulator of XCI.
XO Female genotype with only one X and no Y chromosome.
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